Winton Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Winton Group’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-43,990	Closed	-$2.32M	–	1607
2020 Q3	$2.32M	Sell	43,990 -14,163	-24%	-$874K	0.08%	455
2020 Q2	$3.56M	Buy	58,153 +33,128	+132%	+$1.92M	0.09%	373
2020 Q1	$1.42M	Sell	25,025 -1,402	-5%	-$79.9K	0.04%	671
2019 Q4	$1.5M	Sell	26,427 -7,890	-23%	-$418K	0.02%	902
2019 Q3	$1.84M	Buy	34,317 +27,050	+372%	+$1.57M	0.02%	600
2019 Q2	$434K	Buy	+7,267	New	+$457K	0.01%	731

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Winton Group's BSTC Position: Q4 2020 in Review

Winton Group sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 43,990 shares — an estimated $2.32M sold.

Winton Group first reported a position in BSTC in Q2 2019 and held it in 6 quarters. The position peaked at $3.56M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Winton Group reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Winton Group sold 43,990 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $2.32M.
Winton Group first reported a position in BioSpecifics Technologies Corp. in Q2 2019 and held it in 6 quarters.
Winton Group's BioSpecifics Technologies Corp. position peaked at $3.56M in Q2 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Winton Group's 13F filing for Q4 2020, filed 12 Feb 2021.